CDKN2A and meningioma: Homozygous deletion (homodel) of CDKN2A/B specifically, now a diagnostic criterion for WHO grade 3 meningiomas was found in only 4.5% of all meningiomas (68/1506, Fig. 1e) and 25% of all WHO grade 3 cases (38/148) in our cohort.